ER-Pharma SRL
The score of ER-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +98 % Total assets +51 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ER-Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 22 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
ER-Pharma's financial analysis
- Solvency73.5%sector median: 55.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ER-Pharma
ER-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0791.284.824
- VAT number
- BE0791284824
- Peppol
- Registered · 0208:0791284824 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Sep 2022
- Registered office
- 8500 Kortrijk
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
ER-Pharma (SRL) has been based in Kortrijk since 2022, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 13,994 € and equity of 55,819 €; its revenue is not published. Its solvency stands at 73.5%, above the median of its sector (55.4%).
Companies similar to ER-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Luva Other business support service activities n.e.c. Kortrijk · balance sheet 77,921 €
- Sophie LARET, société de management Other business support service activities n.e.c. Visé · balance sheet 78,439 €
- Go Build Other business support service activities n.e.c. Heist-op-den-Berg · balance sheet 75,868 €
- Meleck Other business support service activities n.e.c. Arendonk · balance sheet 75,791 €
- Nollé Other business support service activities n.e.c. Aalter · balance sheet 75,747 €
- Aurora Venture Management Other business support service activities n.e.c. Schoten · balance sheet 75,213 €
- Ghyselen-Vandenberghe Other business support service activities n.e.c. Bruges · balance sheet 76,665 €
- ANT Works Other business support service activities n.e.c. Antwerp · balance sheet 76,821 €
Frequently asked questions about ER-Pharma
What is the revenue of ER-Pharma?
ER-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ER-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0791284824 for ER-Pharma, if the company is VAT-registered. Its company number (CBE) is 0791.284.824.
Where is the registered office of ER-Pharma?
According to the CBE register, the registered office of ER-Pharma is in 8500 Kortrijk.
What is the equity of ER-Pharma?
At the close of the 2025 financial year, the equity of ER-Pharma amounts to 55,819 €, a solvency of 73.5% of total assets.
Who manages ER-Pharma?
The register lists 1 active mandates at ER-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ER-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →